Hikal - Quaterly Results

09 Nov 2022 Evaluate
The revenue for the September 2022 quarter is pegged at Rs. 5587.50 millions, about 19.12% up against Rs. 4690.60 millions recorded during the year-ago period.Profit after Tax for the quarter ended September 2022 saw a decline of -43.61% from Rs. 440.50 millions to Rs. 248.40  millions.Operating Profit reported a sharp decline to 709.80 millions from 917.60 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 5587.50 4690.60 19.12 9375.40 9258.40 1.26 19427.20 17204.40 12.92
Other Income 12.50 8.70 43.68 45.20 40.50 11.60 48.90 49.80 -1.81
PBIDT 709.80 917.60 -22.65 969.20 1906.60 -49.17 3454.50 3278.70 5.36
Interest 108.00 79.60 35.68 220.90 159.50 38.50 312.10 362.00 -13.78
PBDT 601.80 838.00 -28.19 748.30 1747.10 -57.17 3142.40 2916.70 7.74
Depreciation 274.10 242.00 13.26 539.10 467.60 15.29 956.70 852.40 12.24
PBT 327.70 596.00 -45.02 209.20 1279.50 -83.65 2185.70 2064.30 5.88
TAX 79.30 155.50 -49.00 50.20 334.00 -84.97 580.60 732.80 -20.77
Deferred Tax 25.80 -4.70 -648.94 -3.30 -15.10 -78.15 -15.90 -62.70 -74.64
PAT 248.40 440.50 -43.61 159.00 945.50 -83.18 1605.10 1331.50 20.55
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 12.70 19.56 -35.06 10.34 20.59 -49.80 17.78 19.06 -6.69

Hikal Share Price

242.40 -10.55 (-4.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×